Literature DB >> 3587895

Gaze-evoked amaurosis.

J C Orcutt, W M Tucker, R P Mills, C H Smith.   

Abstract

Gaze-evoked amaurosis is a transient monocular loss of vision occurring in a particular direction of eccentric gaze. Six cases are reported with a mean follow-up of 5 years; three with optic nerve sheath meningiomas and three with orbital cavernous hemangiomas. Five of the six patients have had no visual deterioration during follow-up. Bilateral optic nerve sheath meningiomas led to visual deterioration in both eyes of one patient, but gaze-evoked amaurosis was present in only one eye. The symptom of gaze-evoked amaurosis, while alarming, is not predictive of permanent visual loss. Possible mechanisms for gaze-evoked amaurosis include inhibition of axonal impulses or transient optic nerve ischemia.

Entities:  

Mesh:

Year:  1987        PMID: 3587895     DOI: 10.1016/s0161-6420(87)33471-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  6 in total

1.  Magnetic resonance imaging of the optic nerve in extremes of gaze. Implications for the positioning of the globe for retrobulbar anaesthesia.

Authors:  C Liu; B Youl; I Moseley
Journal:  Br J Ophthalmol       Date:  1992-12       Impact factor: 4.638

2.  [Gaze-evoked amaurosis fugax].

Authors:  J Berglöff; D Mattes; G Brix-Grünwald; R Gröll; M Weger
Journal:  Ophthalmologe       Date:  2006-12       Impact factor: 1.059

3.  Primary and Secondary Optic Nerve Sheath Meningioma.

Authors:  Elena Solli; Roger E Turbin
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

4.  Transient Vision Loss.

Authors:  Carolyn Glazer-Hockstein; Nicholas J. Volpe
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

5.  Diagnostic Considerations in Patients Presenting with Transient Vision Loss.

Authors:  Bokkwan Jun
Journal:  Mo Med       Date:  2016 Jan-Feb

6.  Pseudo-Duane retraction syndrome after orbital myositis.

Authors:  Abdelrahman M Elhusseiny; Gabrielle Fridman; Bharti R Nihalani; Eric D Gaier
Journal:  J AAPOS       Date:  2021-02-27       Impact factor: 1.220

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.